274 related articles for article (PubMed ID: 15037522)
1. Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.
Lecci A; Capriati A; Maggi CA
Br J Pharmacol; 2004 Apr; 141(8):1249-63. PubMed ID: 15037522
[TBL] [Abstract][Full Text] [Related]
2. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
3. Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models.
Lecci A; Carini F; Tramontana M; D'Aranno V; Marinoni E; Crea A; Bueno L; Fioramonti J; Criscuoli M; Giuliani S; Maggi CA
J Pharmacol Exp Ther; 2001 Oct; 299(1):247-54. PubMed ID: 11561086
[TBL] [Abstract][Full Text] [Related]
4. The place of tachykinin NK2 receptor antagonists in the treatment diarrhea-predominant irritable bowel syndrome.
Szymaszkiewicz A; Malkiewicz A; Storr M; Fichna J; Zielinska M
J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31019119
[TBL] [Abstract][Full Text] [Related]
5. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517
[TBL] [Abstract][Full Text] [Related]
6. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum.
Zagorodnyuk V; Santicioli P; Turini D; Maggi CA
Neuropeptides; 1997 Jun; 31(3):265-71. PubMed ID: 9243524
[TBL] [Abstract][Full Text] [Related]
8. Gender-Related Differences of Tachykinin NK
Drimousis S; Markus I; Murphy TV; Perera DS; Phan-Thien KC; Zhang L; Liu L
J Pharmacol Exp Ther; 2020 Oct; 375(1):28-39. PubMed ID: 32764152
[TBL] [Abstract][Full Text] [Related]
9. Influence of tachykinin NK2 receptors on intestinal sensitivity and motility in newborn rats.
Tramontana M; Evangelista S; Giuliani S; Manzini S; Robelet S; Girod V; Maggi CA
Neuropeptides; 2010 Jun; 44(3):269-72. PubMed ID: 20137809
[TBL] [Abstract][Full Text] [Related]
10. Role of tachykinin NK1 and NK2 receptors on colonic motility in anesthetized rats: effect of agonists.
Lecci A; Tramontana M; Giuliani S; Maggi CA
Can J Physiol Pharmacol; 1997 Jun; 75(6):582-6. PubMed ID: 9276132
[TBL] [Abstract][Full Text] [Related]
11. Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome.
Corsetti M; Akyuz F; Tack J
Neurogastroenterol Motil; 2015 Oct; 27(10):1354-70. PubMed ID: 26088804
[TBL] [Abstract][Full Text] [Related]
12. MEN 11420, a potent and selective tachykinin NK2 receptor antagonist in the guinea-pig and human colon.
Santicioli P; Giuliani S; Patacchini R; Tramontana M; Criscuoli M; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):678-88. PubMed ID: 9402049
[TBL] [Abstract][Full Text] [Related]
13. A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine.
Lördal M; Navalesi G; Theodorsson E; Maggi CA; Hellström PM
Br J Pharmacol; 2001 Sep; 134(1):215-23. PubMed ID: 11522614
[TBL] [Abstract][Full Text] [Related]
14. Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig.
Corboz MR; Fernandez X; Rizzo CA; Tozzi S; Monahan ME; Hey JA
Auton Autacoid Pharmacol; 2003 Feb; 23(1):79-93. PubMed ID: 14565542
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tachykinin NK2 receptor on dog proximal colon. Antagonism by MEN 10,627 and SR 48,968.
Parlani M; Conte B; Cirillo R; Manzini S
Eur J Pharmacol; 1996 Dec; 318(2-3):419-24. PubMed ID: 9016933
[TBL] [Abstract][Full Text] [Related]
16. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin NK(2) receptors and enhancement of cholinergic transmission in the inflamed rat colon: an in vivo motility study.
Carini F; Lecci A; Tramontana M; Giuliani S; Maggi CA
Br J Pharmacol; 2001 Aug; 133(7):1107-13. PubMed ID: 11487522
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the guinea-pig stomach.
Zagorodnyuk V; Maggi CA
Neuroscience; 1997 Sep; 80(2):625-34. PubMed ID: 9284363
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin NK
Jung HJ; Priefer R
Auton Neurosci; 2021 Nov; 235():102865. PubMed ID: 34358844
[TBL] [Abstract][Full Text] [Related]
20. Involvement of endogenous tachykinins and CGRP in the motor responses produced by capsaicin in the guinea-pig common bile duct.
Patacchini R; Barthó L; De Giorgio R; Lénárd L; Stanghellini V; Barbara G; Lecci A; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):344-53. PubMed ID: 10543438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
